Associated Papers
Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms.
Baranwal A et al.
Blood Advances, 2024
Mining cancer genomes for change-of-metabolic-function mutations.
Tu KJ et al.
Communications Biology, 2023
37950065 (PubMed )
Supplement: 42003_2023_5475_MOESM2_ESM.pdf
A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation.
Kaneko Y et al.
British Journal of Cancer, 2015
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial.
Renneville A et al.
Oncotarget, 2014
24659740 (PubMed )
Supplement: oncotarget-05-916-s001.pdf
WT1 mutations and polymorphisms in Southeast Asian acute myeloid leukemia.
Lauhakirti D et al.
Experimental and Molecular Pathology, 2011
Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations.
Chernin G et al.
Clinical Journal of the American Society of Nephrology : Cjasn, 2010
Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities.
Haruta M et al.
Genes, Chromosomes & Cancer, 2008
Select a paper to view details